A phase II study of oxaliplatin reintroduction in patients pretreated with oxaliplatin and irinotecan for advanced colorectal cancer (RE-OPEN study).

Authors

null

Mitsukuni Suenaga

Department of Gastroenterology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan

Mitsukuni Suenaga , Nobuyuki Mizunuma , Satoshi Matsusaka , Eiji Shinozaki , Masato Ozaka , Mariko Ogura , Keisho Chin , Toshiharu Yamaguchi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

000004884

Citation

J Clin Oncol 33, 2015 (suppl 3; abstr 758)

DOI

10.1200/jco.2015.33.3_suppl.758

Abstract #

758

Poster Bd #

E48

Abstract Disclosures

Similar Posters

First Author: Mitsukuni Suenaga

First Author: Helena Anna Taflin

Poster

2017 Gastrointestinal Cancers Symposium

A single arm, prospective multicenter phase II study FOLFIRINOX in patients with advanced and recurrent biliary tract cancer.

A single arm, prospective multicenter phase II study FOLFIRINOX in patients with advanced and recurrent biliary tract cancer.

First Author: Naminatsu Takahara